Alignment Healthcare, Inc.
ALHC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $994 | $1,015 | $927 | $701 |
| % Growth | -2.1% | 9.5% | 32.2% | – |
| Cost of Goods Sold | $868 | $882 | $821 | $615 |
| Gross Profit | $126 | $134 | $106 | $86 |
| % Margin | 12.6% | 13.2% | 11.4% | 12.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $95 |
| SG&A Expenses | $110 | $104 | $104 | $101 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $6 |
| Other Operating Expenses | $8 | $7 | $8 | $8 |
| Operating Expenses | $118 | $111 | $111 | $109 |
| Operating Income | $8 | $23 | -$5 | -$23 |
| % Margin | 0.8% | 2.2% | -0.6% | -3.2% |
| Other Income/Exp. Net | -$4 | -$4 | -$4 | -$9 |
| Pre-Tax Income | $4 | $19 | -$9 | -$31 |
| Tax Expense | $0 | $3 | $0 | $0 |
| Net Income | $4 | $16 | -$9 | -$31 |
| % Margin | 0.4% | 1.5% | -1% | -4.4% |
| EPS | 0.019 | 0.079 | -0.047 | -0.16 |
| % Growth | -76.3% | 267.7% | 70.6% | – |
| EPS Diluted | 0.018 | 0.075 | -0.047 | -0.16 |
| Weighted Avg Shares Out | 199 | 198 | 194 | 192 |
| Weighted Avg Shares Out Dil | 209 | 210 | 194 | 192 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4 | $4 | $4 | $5 |
| Depreciation & Amortization | $8 | $7 | $8 | $7 |
| EBITDA | $16 | $30 | $2 | -$19 |
| % Margin | 1.6% | 2.9% | 0.2% | -2.7% |